M. Saunders

791 total citations
24 papers, 506 citations indexed

About

M. Saunders is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, M. Saunders has authored 24 papers receiving a total of 506 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 7 papers in Pathology and Forensic Medicine and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in M. Saunders's work include Lymphoma Diagnosis and Treatment (6 papers), Lung Cancer Treatments and Mutations (6 papers) and Colorectal Cancer Treatments and Studies (5 papers). M. Saunders is often cited by papers focused on Lymphoma Diagnosis and Treatment (6 papers), Lung Cancer Treatments and Mutations (6 papers) and Colorectal Cancer Treatments and Studies (5 papers). M. Saunders collaborates with scholars based in United States, United Kingdom and France. M. Saunders's co-authors include Owen A. O’Connor, Stanley Dische, I. R. Flockhart, Peter J. Anderson, Sarah McCue Horwitz, Nancy L. Bartlett, Mary Jo Lechowicz, Andrei R. Shustov, Jasmine Zain and Maria Delioukina and has published in prestigious journals such as Journal of Clinical Oncology, Blood and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

M. Saunders

24 papers receiving 487 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Saunders United States 12 182 145 143 129 71 24 506
T. Megha Italy 9 190 1.0× 41 0.3× 216 1.5× 76 0.6× 157 2.2× 15 504
C. von Schilling Germany 11 185 1.0× 40 0.3× 178 1.2× 134 1.0× 98 1.4× 22 498
Gabriel Prolla Brazil 8 158 0.9× 51 0.4× 196 1.4× 118 0.9× 97 1.4× 17 427
S. Vukelja United States 10 67 0.4× 106 0.7× 707 4.9× 80 0.6× 179 2.5× 30 911
Martin E. Bur United States 11 202 1.1× 60 0.4× 214 1.5× 106 0.8× 172 2.4× 17 825
Hong Yi Wang United States 7 205 1.1× 69 0.5× 531 3.7× 383 3.0× 175 2.5× 12 791
Paulo Lúcio Portugal 13 163 0.9× 79 0.5× 160 1.1× 144 1.1× 255 3.6× 30 854
F. Moritz Germany 7 139 0.8× 44 0.3× 87 0.6× 136 1.1× 289 4.1× 16 519
Naresh Punwani United States 12 75 0.4× 124 0.9× 241 1.7× 224 1.7× 178 2.5× 17 803
Andrew P. Sciallis United States 15 121 0.7× 53 0.4× 254 1.8× 46 0.4× 225 3.2× 39 770

Countries citing papers authored by M. Saunders

Since Specialization
Citations

This map shows the geographic impact of M. Saunders's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Saunders with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Saunders more than expected).

Fields of papers citing papers by M. Saunders

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Saunders. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Saunders. The network helps show where M. Saunders may publish in the future.

Co-authorship network of co-authors of M. Saunders

This figure shows the co-authorship network connecting the top 25 collaborators of M. Saunders. A scholar is included among the top collaborators of M. Saunders based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Saunders. M. Saunders is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
MacRae, Calum A., Matthew R.G. Taylor, Luisa Mestroni, et al.. (2022). Efficacy and Safety of ARRY-371797 in LMNA -Related Dilated Cardiomyopathy: A Phase 2 Study. Circulation Genomic and Precision Medicine. 16(1). e003730–e003730. 12 indexed citations
2.
Robinson, Michael F., Nemanja Damjanov, Bojana Stamenković, et al.. (2020). Efficacy and Safety of PF‐06651600 (Ritlecitinib), a Novel JAK3/TEC Inhibitor, in Patients With Moderate‐to‐Severe Rheumatoid Arthritis and an Inadequate Response to Methotrexate. Arthritis & Rheumatology. 72(10). 1621–1631. 64 indexed citations
3.
4.
Horwitz, Sarah McCue, Youn H. Kim, Francine Foss, et al.. (2012). Identification of an active, well-tolerated dose of pralatrexate in patients with relapsed or refractory cutaneous T-cell lymphoma. Blood. 119(18). 4115–4122. 101 indexed citations
5.
Azzoli, Christopher G., Jyoti D. Patel, Lee M. Krug, et al.. (2011). Pralatrexate with Vitamin Supplementation in Patients with Previously Treated, Advanced Non-small Cell Lung Cancer: Safety and Efficacy in a Phase 1 Trial. Journal of Thoracic Oncology. 6(11). 1915–1922. 10 indexed citations
6.
Izbicka, Elżbieta, et al.. (2009). Distinct mechanistic activity profile of pralatrexate in comparison to other antifolates in in vitro and in vivo models of human cancers. Cancer Chemotherapy and Pharmacology. 64(5). 993–999. 44 indexed citations
7.
Mould, Diane R., Kevin Sweeney, Stephen B. Duffull, et al.. (2009). A Population Pharmacokinetic and Pharmacodynamic Evaluation of Pralatrexate in Patients With Relapsed or Refractory Non-Hodgkin's or Hodgkin's Lymphoma. Clinical Pharmacology & Therapeutics. 86(2). 190–196. 28 indexed citations
8.
O’Connor, Owen A., Barbara Pro, Lauren Pinter‐Brown, et al.. (2009). PROPEL: Results of the pivotal, multicenter, phase II study of pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma (PTCL). Journal of Clinical Oncology. 27(15_suppl). 8561–8561. 20 indexed citations
9.
10.
Horwitz, Sarah McCue, Julie M. Vose, Ranjana H. Advani, et al.. (2008). A Phase 1/2A Open-Label Study of Pralatrexate and Gemcitabine in Patients with Relapsed or Refractory Lymphoproliferative Malignancies.. Blood. 112(11). 1570–1570. 5 indexed citations
11.
Oelschlager, Brant K., Wui‐Jin Koh, M. Saunders, et al.. (2008). Phase I trial with weekly docetaxel, capecitabine and carboplatin followed by concomitant capecitabine and radiation in patients with locally advanced esophageal cancer. Journal of Clinical Oncology. 26(15_suppl). 15501–15501. 2 indexed citations
12.
James, Leonard P., Christopher G. Azzoli, Lee M. Krug, et al.. (2007). Phase I study of the anitfolate pralatrexate given with vitamin B12 and folic acid supplementation in patients with advanced non-small cell lung cancer (NSCLC). Molecular Cancer Therapeutics. 6. 1 indexed citations
13.
Saunders, M., Eric Van Cutsem, R. Wilson, et al.. (2007). Vandetanib with FOLFIRI in patients with advanced colorectal adenocarcinoma: an open-label, multicenter Phase I study. Journal of Clinical Oncology. 25(18_suppl). 4085–4085. 3 indexed citations
14.
Gollins, Simon, Swe Swe Myint, Edward A. Levine, et al.. (2005). Phase I study of radiotherapy (RT) plus concurrent irinotecan (CPT-11) and capecitabine (CAP) as preoperative downstaging treatment for locally advanced inoperable rectal cancer. Journal of Clinical Oncology. 23(16_suppl). 3565–3565. 11 indexed citations
15.
Levine, E.L., Simon Gollins, S. Susnerwala, et al.. (2004). Phase II study of radiotherapy plus concurrent irinotecan (CPT-11) and infusional 5-fluorouracil (5FU) in the treatment of T3-T4 locally advanced inoperable rectal cancer. Journal of Clinical Oncology. 22(14_suppl). 3612–3612. 7 indexed citations
16.
Schubert, Armin, Robert J. Przybelski, John F. Eidt, et al.. (2003). Diaspirin-Crosslinked Hemoglobin Reduces Blood Transfusion in Noncardiac Surgery: A Multicenter, Randomized, Controlled, Double-Blinded Trial. Anesthesia & Analgesia. 97(2). 323–332. 46 indexed citations
17.
Leak, Lee V., M. Saunders, Agnes Day, & Michael Jones. (2000). Stimulation of Plasminogen Activator and Inhibitor in the Lymphatic Endothelium. Microvascular Research. 60(3). 201–211. 8 indexed citations
18.
Saunders, M. & Ruth Grant. (1998). Cost effectiveness of low-molecular weight heparin versus warfarin following hip replacement surgery.. PubMed. 90(11). 677–80. 12 indexed citations
19.
Saunders, M., Stanley Dische, Peter J. Anderson, & I. R. Flockhart. (1978). The neurotoxicity of misonidazole and its relationship to dose, half-life and concentration in the serum.. PubMed. 3. 268–70. 47 indexed citations
20.
Cumming, W. J. K. & M. Saunders. (1978). Radiculopathy as a complication of ankylosing spondylitis.. Journal of Neurology Neurosurgery & Psychiatry. 41(6). 569–570. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by T. Megha Breakdown of academic impact, for papers by C. von Schilling Breakdown of academic impact, for papers by Gabriel Prolla Breakdown of academic impact, for papers by S. Vukelja Breakdown of academic impact, for papers by Martin E. Bur Breakdown of academic impact, for papers by Hong Yi Wang Breakdown of academic impact, for papers by Paulo Lúcio Breakdown of academic impact, for papers by F. Moritz Breakdown of academic impact, for papers by Naresh Punwani Breakdown of academic impact, for papers by Andrew P. Sciallis
Rankless by CCL
2026